Find Clinical Trials | Cedars-Sinai

7 results found

Crohn's disease [regional enteritis], IBD, Inflammatory Bowel Disease

Tulisokibart in Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called tulisokibart (MK-7240) in people with moderately to severely active Crohn’s disease that has not responded well to treatment. ...

Crohn's disease [regional enteritis], IBD, Inflammatory Bowel Disease

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

The purpose of this study is to evaluate the effectiveness of an experimental drug called tirzepatide for the treatment of Crohn’s disease. Participants will be randomly assigned to 1 of 2 groups. Group 1 will ...

IBD, Inflammatory Bowel Disease, Ulcerative colitis

Mirikizumab Administered With Tirzepatide in Ulcerative Colitis and Obesity or Overweight

The purpose of this study is to evaluate a drug called mirikizumab when taken with another drug, tirzepatide, for the treatment of ulcerative colitis in patients with excess weight or obesity. Mirikizumab may have anti-inflammatory ...

Crohn's disease [regional enteritis], IBD, Inflammatory Bowel Disease

EliLilly_ I6T-MC-AMCE_Mirikizumab with Tirzepatide in Adult Participants with Crohn's Disease

To evaluate if concomitant administration of mirikizumab and tirzepatide at the MTD (up to 15 mg) is superior to mirikizumab and placebo in simultaneously achieving clinical remission, endoscopic remission, and weight reduction

Inflammatory Bowel Disease

Treat-to-Target of Endoscopic Remission in Patients with IBD in Symptomatic Remission

The purpose of this study is to collect and analyze data in patients with inflammatory bowel disease (IBD) who are currently receiving IBD medication(s) that targets their immune system (targeted immunomodulator- TIM) in routine clinical ...